Company integrates leading medical imaging technology with image management and reporting system provided by Digisonics.
Boston, MA-June 2, 2008-Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation, today announced that it has integrated its leading medical imaging technology with the functionality of DigiView, a specialized image management and reporting system provided by Digisonics, to offer clients expanded capabilities for cardiac function assessment in clinical studies. The system provides high-performance electronic review, analysis, reporting, and archiving of medical images related to cardiac function assessment. Cardiac function assessment is required for a broad range of therapeutic area research, including cardiology, oncology, central nervous system, and metabolism/endocrinology studies.
As cardiac safety has become a greater regulatory focus for various compounds, biopharmaceutical companies increasingly turn to us for cardiac evaluations to support the demonstration of safety and efficacy," said Todd A. Joron, corporate vice president and general manager of Perceptive Informatics at PAREXEL International. "By combining this tool with our leading medical imaging technology and in-depth expertise, we are able to help clients better meet their cardiovascular imaging needs."
The integrated Perceptive and DigiView system, which supports various cardiovascular imaging modalities, provides several capabilities, including faster, more accurate review of cardiac images as well as automatic synchronization of image analysis findings with other clinical data through an electronic Case Report Form. The system provides an electronic record of all image analysis versions and exceeds HIPAA requirements for providing security and a regulatory audit trail, as well as capturing electronic signatures. Perceptive Informatics' medical imaging technology is fully validated and in compliance with regulatory guidelines.
The Perceptive Informatics Medical Imaging division leverages advanced technology to help ensure the effective use of imaging surrogate endpoint data as well as secure data access and back-up. The Perceptive Informatics medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.